Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Sheel Biotech's Enterprise Value is ₹1,452 Mil.
Sheel Biotech's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹159 Mil. Therefore, Sheel Biotech's EV-to-EBIT ratio for today is 9.11.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Sheel Biotech's Enterprise Value is ₹1,452 Mil.
Sheel Biotech's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹170 Mil. Therefore, Sheel Biotech's EV-to-EBITDA ratio for today is 8.54.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Sheel Biotech's Enterprise Value is ₹1,452 Mil.
Sheel Biotech's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was ₹1,100 Mil. Therefore, Sheel Biotech's EV-to-Revenue ratio for today is 1.32.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Sheel Biotech's Enterprise Value is ₹1,452 Mil.
Sheel Biotech's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-242 Mil. Therefore, Sheel Biotech's EV-to-FCF ratio for today is -5.99.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Sheel Biotech (NSE:SHEEL) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Sheel Biotech's current Enterprise Value is ₹1,452 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sheel Biotech's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹159 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Sheel Biotech's current Enterprise Value is ₹1,452 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sheel Biotech's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹170 Mil.
Sheel Biotech's current Enterprise Value is ₹1,452 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sheel Biotech's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was ₹1,100 Mil.
Sheel Biotech's current Enterprise Value is ₹1,452 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sheel Biotech's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-176 Mil.
Sheel Biotech's current Enterprise Value is ₹1,452 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sheel Biotech's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-242 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sheel Biotech Enterprise Value Related Terms
Sheel Biotech Enterprise Value Historical Data
* Premium members only.
The historical data trend for Sheel Biotech's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sheel Biotech Enterprise Value Chart
Sheel Biotech Annual Data
Trend
Mar22
Mar23
Mar24
Mar25
Mar26
Enterprise Value
0.00
0.00
0.00
0.00
882.08
Sheel Biotech Semi-Annual Data
Mar22
Mar23
Mar24
Mar25
Mar26
Enterprise Value
0.00
0.00
0.00
0.00
882.08
NSE:SHEEL vs ADM, BG, TSN: Enterprise Value Comparison
For the Farm Products subindustry, Sheel Biotech's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sheel Biotech Enterprise Value vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Sheel Biotech's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Sheel Biotech's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Sheel Biotech's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sheel Biotech (NSE:SHEEL) has a Enterprise Value of ₹1,452 Mil as of Jul. 26, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Sheel Biotech and its competitors.
Is Sheel Biotech's Enterprise Value too high?
Sheel Biotech's current Enterprise Value is ₹1,452 Mil. Overall, Sheel Biotech has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sheel Biotech's Enterprise Value compare to ADM and BG?
Sheel Biotech's Enterprise Value of ₹1,452 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Consumer Packaged Goods company?
A good Enterprise Value depends on the Consumer Packaged Goods industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Sheel Biotech and its competitors. Sheel Biotech's current Enterprise Value is ₹1,452 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sheel Biotech stock overvalued right now?
Sheel Biotech (NSE:SHEEL) has a current Enterprise Value of ₹1,452 Mil. The current Enterprise Value is ₹1,452 Mil. Sheel Biotech's overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Sheel Biotech (NSE:SHEEL), the current Enterprise Value is ₹1,452 Mil as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sheel Biotech Ltd is engaged in the business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. It manufactures and maintain greenhouses, offer services to farmers and provide training through Farmer Producer Organizations (FPOs). The company also has a Research and Development lab with a capacity of production of 10 million* planting materials which is duly recognized by the Department of Biotechnology (DBT), Government of India.
18GF Score
Get the complete analysis for NSE:SHEEL
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SHEEL has been successfully added to your 
